This drug is only used if:
- tests show you have a faulty BRCA1 or BRCA2 gene
- certain types of chemotherapy drug are controlling the cancer effectively.
You have a course of chemotherapy before you start olaparib. The chemotherapy gets rid of as much of the cancer as possible. You then take olaparib capsules twice a day to stop the cancer growing again. Your cancer doctor or nurse will explain how long you can keep taking olaparib.
Some people may have this drug as part of a cancer research trial (clinical trial). But bevacizumab is not widely available through the NHS.
When a drug is not available through the NHS, it may still be possible to access it in some situations. Your cancer doctor can give you advice about this.
We have more information about what you can do if a treatment is not available.
Below is a sample of the sources used in our ovarian cancer information. If you would like more information about the sources we use, please contact us at firstname.lastname@example.org
Fotopoulou C, et al. British Gynaecological Cancer Society (BGCS) epithelial ovarian/ fallopian tube/ primary peritoneal cancer guidelines: recommendations for practice. European Journal of Obstetrics, gynecology, and reproductive biology. 2017. 213: 123-139.
National Institute for Health and Care Excellence. Ovarian cancer: recognition and initial management. Clinical guideline (CG122). April 2011. Available from: www.nice.org.uk/Guidance/CG122 (accessed June 2017).
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer. It has been approved by Senior Medical Editor, Professor David Luesley, Professor of Gynaecological Oncology.
Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.